ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CL1348A |
|
1415246-68-2 |
MMAF Hydrochloride;Monomethylauristatin F Hydrochloride 98+% |
C39H66ClN5O8 | |
CLA1358 |
|
1342290-43-0 |
Abrilumab (Anti-Integrin a4b7 ITGA4 & ITGB7) 95+% |
— | |
CLA1352 |
|
1105038-73-0 |
Abituzumab (Anti-Integrin aV / ITGAV / CD51) 95+% |
— | |
CLA1265 |
|
1044758-60-2 |
Etrolizumab (Anti-Integrin α4β7) (ITGA4 & ITGB7) 95+% |
— | |
CLA1226 |
|
339086-79-2 |
Rovelizumab 95+% |
— | |
CLA1211 |
|
211323-03-4 |
Erlizumab (Anti-Integrin b2 / ITGB2 / CD18) 95+% |
— | |
CLA1196 |
|
558480-40-3 |
Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1)) 95+% |
— | |
CLA1185 |
|
892553-42-3 |
Etaracizumab 95+% |
— | |
CLA1118 |
|
143653-53-6 |
Abciximab 95+% |
— | |
CLA1108 |
|
159445-64-4 |
Odulimomab 95+% |
— | |
CLA1097 |
|
142864-19-5 |
Enlimomab 95+% |
— | |
CLA1084 |
|
339086-80-5 |
Tadocizumab 95+% |
— | |
CLA1062 |
|
214745-43-4 |
Anti-Human CD11a Monoclonal Antibody(Efalizumab) 95+% |
— | |
CL2010 |
|
59917-39-4 |
Vindesine Sulfate Salt 98+% |
C43H57N5O11S | |
HL1056 |
|
33069-62-4 |
Natural Paclitaxel 98+% |
C47H51NO14 | |
CL1064A |
|
148408-66-6 |
Docetaxel Trihydrate 99+% |
C43H53NO14.3H2O | |
CL1668 |
|
2068-78-2 |
Vincristine sulfate (Leurocristine sulfate; 22-Oxovincaleukoblastine sulfate); Vincristine Sulphate 98+% |
C46H58N4O14S | |
CLA1024 |
|
189261-10-7 |
Natalizumab 98+% |
— | |
CLA1011 |
|
943609-66-3 |
Vedolizumab 98+% |
— | |
CL1020 |
|
78432-77-6 |
7-Epi-10-Deacetyl Paclitaxel 98+% |
C45H49NO13 | |